The Caudate Nucleus Undergoes Dramatic and Unique Transcriptional Changes in Human Prodromal Huntington’s Disease Brain
Filisia AgusiD, Diego Crespo, Richard H. MyersiD, Adam Thomas LabadorfiD
Abstract
The mechanisms underlying degeneration of the specific neurons in the striatum of Huntingons Disease (HD) brain are currently unknown. The striatum is massively degenerated in late stage HD, making examination of post-mortem brain tissue from symptomatic individuals problematic. Striatal tissue is largely intact in the brains of asymptomatic HD positive (HD+) gene carriers, but these samples are exceedingly rare. In this study, caudate nucleus (CAU) tissue from two asymptomatic HD+ individuals was subjected to high throughput mRNA sequencing (mRNA-Seq) for comparison with similar datasets from symptomatic HD individuals and healthy controls. The overall transcriptional response in HD+ CAU shares much of the same response observed in HD Brodmann Area 9 (BA9) samples, an area that is relatively spared from significant degeneration. A set of differentially expressed (DE) genes predominantly related to the heat shock response are found in common between brain regions, and show much higher induction in HD+ CAU than HD BA9. The most highly perturbed pathways show near complete agreement when comparing diseased tissue with control, and a random forest classifier predicted that the two HD+ CAU samples strongly resemble HD BA9 and not control BA9. Nonetheless, when genes were prioritized by their specificity to HD+ CAU, a large number of pathways spanning many biological processes emerged. Further comparison of HD+ BA9 with HD BA9 identified genes that may be early responders to disease, and have altered expression in symptomatic individuals. This study presents the first and largest examination of asymptomatic brain gene expression to date, and suggests many new avenues of investigation into the mechanisms underlying neurodegeneration in HD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 51
- FWCI
- 3.34
- Field percentile
- top 6%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell-specific transcription dysregulation in human Huntington's disease-positive developing striatum
Sophie V. Precious, Oliver J.M. Bartley, … Anne Rosser·bioRxiv·Jun 19, 2026
- Single-nucleus RNA-seq reveals dysregulation of striatal cell identity due to Huntington’s disease mutations
Sonia Malaiya, Marcia Cortes-Gutierrez, … Seth A. Ament·Journal of NeurosciencePeer-reviewed·May 19, 2021
- Huntingtin loss-of-function contributes to transcriptional deregulation in Huntington's disease
Emilia Kozłowska, Agata Ciołak, … Agnieszka Fiszer·Cell & BiosciencePeer-reviewed·Jul 9, 2025
- Somatic DNA-repeat expansions initiate distinct yet analogous changes in Huntington's disease cortical and striatal neurons
Seva Kashin, Won‐Seok Lee, … Steven A. McCarroll·CellPeer-reviewed·Oct 1, 2026
- Huntington's Disease Produces Multiplexed Transcriptional Vulnerabilities of StriatalD1-D2 and Striosome-Matrix Neurons
A. Matsushima, Sergio Sebastian Pineda, … Ann M. Graybiel·bioRxiv·Apr 25, 2022
- Mapping the glial transcriptome in Huntington's disease using snRNAseq: Selective disruption of glial signatures across brain regions
Sunniva M. K. Bøstrand, Luise A. Seeker, … Anna Williams·Acta Neuropathologica CommunicationsPeer-reviewed·Oct 20, 2024